Surgery of Dystonia
Condition(s) studied
Investigational drug(s) / intervention(s)
deep brain stimulation: Stereotactic implantation of DBS electrodes with chronic electrical stimulation of target nuclei for dystonia. or Stereotactic radiofrequency ablation of dystonia-related target nuclei.
Study summary
The goal of this clinical trial is to evaluate the safety and clinical outcomes of stereotactic surgery (Deep Brain Stimulation or Radiofrequency Lesioning) in patients with dystonia.
The main questions it aims to answer are:
* Does stereotactic surgery improve dystonia severity as measured by the Burke-Fahn-Marsden Dystonia Rating Scale - Motor (BFMDRS-M)?
* Are the procedures safe, with an acceptable complication profile during follow-up?
Participants will:
* Undergo stereotactic surgery for dystonia (either Deep Brain Stimulation or Radiofrequency Lesioning, based on clinical indication).
* Be followed postoperatively for assessment of motor function and adverse events at the first postoperative week and six months after surgery.
Eligibility
Primary outcome measure(s)
- Improvement in Dystonia Severity (BFMDRS-Motor Score) — From baseline (within 4 weeks prior to surgery) to the first postoperative week and up to 6 months postoperatively.
Change in motor severity of dystonia as assessed by the Burke-Fahn-Marsden Dystonia Rating Scale - Motor Subscale (BFMDRS-M; range 0-120, higher scores = worse dystonia). The primary endpoint is the percent change from baseline to follow-up.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sohag Faculity of Medicine | Sohag | Egypt |
More Sohag University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07140302 on ClinicalTrials.gov ↗ ← All trials in Egypt